[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-AARD":3,"homepage-market-summary":28,"stock-news-AARD":170},{"ticker":4,"date":5,"profile":6,"quote":14},"AARD","2026-10-01",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9},"Aardvark Therapeutics, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.","40","San Diego, CA",{"close":15,"open":16,"high":17,"low":18,"prev_close":15,"change":19,"percent_change":19,"volume":20,"transactions":21,"vwap":22,"high_52w":23,"low_52w":24,"avg_volume_52w":25,"range_52w_percent":26,"record_count":27},5.27,5.29,5.42,5.13,0,47823.225527,1065,5.2891,19.58,3.35,181468.98031947072,11.8,410,{"status":29,"indices":30,"watchlist":72,"sectors":95,"benchmarks":150},"success",[31,39,46,53,59,66],{"symbol":32,"name":33,"price":34,"change":35,"pct_change":36,"is_up":37,"sparkline":38,"date":5},"SPX","S&P 500",7666.45,14.91,0.19,true,"0.0,3.1 2.3,5.0 4.6,8.0 6.9,10.4 9.3,13.4 11.6,9.1 13.9,11.5 16.2,13.8 18.5,16.0 20.8,10.3 23.2,9.5 25.5,2.0 27.8,2.0 30.1,5.9 32.4,6.0 34.7,3.4 37.1,7.3 39.4,8.2 41.7,9.4 44.0,8.5",{"symbol":40,"name":41,"price":42,"change":43,"pct_change":44,"is_up":37,"sparkline":45,"date":5},"NDX","NASDAQ 100",30501.56,93.06,0.31,"0.0,11.8 2.3,11.3 4.6,11.6 6.9,12.2 9.3,14.7 11.6,12.6 13.9,14.5 16.2,16.0 18.5,15.9 20.8,12.0 23.2,10.5 25.5,4.0 27.8,2.0 30.1,4.0 32.4,4.0 34.7,3.0 37.1,5.6 39.4,5.1 41.7,4.5 44.0,3.8",{"symbol":47,"name":48,"price":49,"change":50,"pct_change":51,"is_up":37,"sparkline":52,"date":5},"DJI","DOW JONES",50927,21,0.04,"0.0,2.0 2.3,3.4 4.6,6.5 6.9,8.6 9.3,10.2 11.6,7.6 13.9,8.4 16.2,10.0 18.5,13.2 20.8,11.6 23.2,12.1 25.5,10.2 27.8,11.2 30.1,12.9 32.4,13.8 34.7,11.4 37.1,13.1 39.4,13.8 41.7,16.0 44.0,15.9",{"symbol":54,"name":55,"price":56,"change":57,"pct_change":51,"is_up":37,"sparkline":58,"date":5},"COMP","NASDAQ Composite",26871.6,10.53,"0.0,9.3 2.3,10.2 4.6,11.1 6.9,13.0 9.3,14.9 11.6,12.1 13.9,13.7 16.2,16.0 18.5,16.0 20.8,11.1 23.2,10.0 25.5,3.4 27.8,2.0 30.1,5.4 32.4,5.4 34.7,3.9 37.1,6.7 39.4,6.9 41.7,6.2 44.0,6.1",{"symbol":60,"name":61,"price":62,"change":63,"pct_change":64,"is_up":37,"sparkline":65,"date":5},"RUT","RUSSELL 2000",2790.2,11.3,0.41,"0.0,2.6 2.3,2.0 4.6,3.0 6.9,6.1 9.3,8.4 11.6,7.5 13.9,8.8 16.2,10.4 18.5,11.3 20.8,10.2 23.2,11.2 25.5,10.1 27.8,8.8 30.1,12.9 32.4,13.1 34.7,12.8 37.1,14.4 39.4,15.1 41.7,16.0 44.0,15.1",{"symbol":67,"name":68,"price":69,"change":70,"pct_change":44,"is_up":37,"sparkline":71,"date":5},"VIX","CBOE VIX",16.39,0.05,"0.0,15.6 2.3,14.8 4.6,10.2 6.9,7.3 9.3,2.0 11.6,9.7 13.9,4.9 16.2,4.5 18.5,2.5 20.8,11.3 23.2,13.7 25.5,13.5 27.8,16.0 30.1,12.3 32.4,10.4 34.7,13.5 37.1,8.8 39.4,8.9 41.7,7.8 44.0,7.6",[73,80,88],{"symbol":74,"name":75,"price":76,"change":77,"pct_change":78,"is_up":37,"sparkline":79,"date":5},"NVDA","NVIDIA Corp",230.86,2.48,1.09,"0.0,13.9 7.3,16.0 14.7,14.9 22.0,6.5 29.3,10.1 36.7,7.5 44.0,2.0",{"symbol":81,"name":82,"price":83,"change":84,"pct_change":85,"is_up":86,"sparkline":87,"date":5},"AAPL","Apple Inc",330.32,-2.7,-0.81,false,"0.0,6.9 7.3,8.2 14.7,2.0 22.0,5.2 29.3,16.0 36.7,11.7 44.0,14.9",{"symbol":89,"name":90,"price":91,"change":92,"pct_change":93,"is_up":86,"sparkline":94,"date":5},"TSLA","Tesla Inc",354.11,-0.7,-0.2,"0.0,2.0 7.3,3.1 14.7,6.1 22.0,13.6 29.3,16.0 36.7,15.0 44.0,15.3",[96,101,106,111,116,121,126,131,135,140,145],{"name":97,"etf":98,"change":99,"price":100,"is_up":37},"Technology","XLK",1.05,197.81,{"name":102,"etf":103,"change":104,"price":105,"is_up":37},"Financials","XLF",0.11,53.46,{"name":107,"etf":108,"change":109,"price":110,"is_up":86},"Healthcare","XLV",-1.32,166.2,{"name":112,"etf":113,"change":114,"price":115,"is_up":86},"Consumer Cycl","XLY",-0.03,108.81,{"name":117,"etf":118,"change":119,"price":120,"is_up":86},"Consumer Staples","XLP",-0.33,80.33,{"name":122,"etf":123,"change":124,"price":125,"is_up":37},"Energy","XLE",1.95,62.7,{"name":127,"etf":128,"change":129,"price":130,"is_up":37},"Industrials","XLI",0.99,168.64,{"name":132,"etf":133,"change":119,"price":134,"is_up":86},"Materials","XLB",48.54,{"name":136,"etf":137,"change":138,"price":139,"is_up":86},"Real Estate","XLRE",-0.56,40.68,{"name":141,"etf":142,"change":143,"price":144,"is_up":37},"Utilities","XLU",0.61,39.68,{"name":146,"etf":147,"change":148,"price":149,"is_up":86},"Comm Services","XLC",-0.93,109.94,[151,156,160,165],{"ticker":152,"name":153,"price":154,"change":155,"is_up":37},"SPY","SPDR S&P 500 ETF",763.99,0.18,{"ticker":157,"name":158,"price":159,"change":44,"is_up":37},"QQQ","Invesco QQQ Trust",742.03,{"ticker":161,"name":162,"price":163,"change":164,"is_up":37},"DIA","SPDR Dow Jones ETF",508.68,0.03,{"ticker":166,"name":167,"price":168,"change":169,"is_up":37},"IWM","iShares Russell 2000",279.06,0.42,{"ticker":4,"count":171,"articles":172},14,[173,179,185,191,197,202,207,212,217,222,227,232,237,242],{"title":174,"link":175,"pubDate":176,"description":177,"source":178},"AARD Stock News: Robbins LLP Reminds Aardvark Therapeutics, Inc. Stockholders to Contact the Firm Before the October 13, 2026 Lead Plaintiff Deadline - PR Newswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAJBVV95cUxONjJzU3A0Ui1rN2JhbkpRSzFteEdZUFpkWTF6Z0VUblRGS2pyRzY2YVk3VERKSFdTN3d5bmlyY0NFVDEyUkUtYzZRa3J4MUFXVHpIMlR6MHlDWXJLUjluaWlEclc5TXdYRzFTNVBleEY4UlVSVzVkVjhZNEVxQzhYRmZhdFpYX1ZKTkhmNDFCbm1nYmUzZmstcVM2eDZsWG5EX0xUUXVIVUNLbW5PNG9lOUx4bDJibnUyLVhVa3hCMmZQNHFlcFc5N2VrYXljOWtSckExSUNCeTE5Y05iSnFneWRtM3o2Qk1Fa3hCNFlxM0V1WDRudl9YNTVFU2llUk5Nc3o5a25uc1FTcG9sZlhYNE5PdFpPUU91QVpwRXJHM3dUMlJFNm0xNw?oc=5","Wed, 30 Sep 2026 21:58:00 GMT","AARD Stock News: Robbins LLP Reminds Aardvark Therapeutics, Inc. Stockholders to Contact the Firm Before the October 13, 2026 Lead Plaintiff Deadline PR Newswire","PR Newswire",{"title":180,"link":181,"pubDate":182,"description":183,"source":184},"Levi & Korsinsky Reminds Aardvark Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 13, 2026 - AARD - Morningstar","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirwJBVV95cUxQX09pdkVQYTdYdE1NeTdFSXd3MW12VnIxNlBJcWpMZlFLOC1YMmtyZXA0VDllUFgza2xOa0pXTXVVaS1qc3IwVWVrNjFWVkc2c2J1eklWdUI2S3JWT2RtSmxhQlFUNnVWWFVUdXZCYkNCZG9BOERmQXhQVTRBZHYwNUZhNXRVOVhKaDM2dlh0aUdHSFFJM0dYbF8zd01nUU9LUmJjck1hODMzRnFhN2VEVUlDUHRldlBPTGQySDQtQVVxLWE5Y0w1RGl3SERETHBETGY0Mkx1VDViZURkbzZIMGJPRC1NWFdCN21tNVpVZDlMVERKem1VTHZaU0FaRDVWYVh5N1BfNC0ySmN6Sk0xb3Nidm1sQ2RfODhsazRnVjRJaDFmbDZERjVrLXFicVU?oc=5","Wed, 23 Sep 2026 14:09:00 GMT","Levi & Korsinsky Reminds Aardvark Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 13, 2026 - AARD Morningstar","Morningstar",{"title":186,"link":187,"pubDate":188,"description":189,"source":190},"AARDVARK THERAPEUTICS, INC. (AARD) SHAREHOLDER ALERT - GlobeNewswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgJBVV95cUxPby1FazNTV241QmNzWElQR2NIT0tXNlJUMzNjck1HWnNVY3NrWUs3V282anktY0hTa0FqYWVDcHZYcTBoUjJVb0RLREFKanJJR1Z4bm9LR2gxS3hVLTEwcThXS1lfWWgxWnVlZFoxOFhVQThYakV5VHF4MlpBeFc5NG1hVHljMDhHMnd4SUxham9yRlEwVFMxb3JJV19fRllxX3ZMMzRCZWJncnFtRTZIdnVOMGNUTHBobVZaWDhSS1NxYW9Gb195UkVzNk5aRDVIOVJJY3FPcG9JeHhsSEs4amdWbm41X3l4NVdwbTZtZ0pxbzFGa3Vqdm5XUFdESkQwVkVTXzQ2cGQ1WDZKbW53djY0WGpDcjdBVWUyRVRxZllrc0dDLVY0Z3BmaTMtd0FqVlE?oc=5","Wed, 30 Sep 2026 13:03:00 GMT","AARDVARK THERAPEUTICS, INC. (AARD) SHAREHOLDER ALERT GlobeNewswire","GlobeNewswire",{"title":192,"link":193,"pubDate":194,"description":195,"source":196},"The Technical Signals Behind (AARD) That Institutions Follow - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1AFBVV95cUxQWFBaSkFOdVhzZWtTMUVkSVA4MUFlZlZYelZUVnFEZS1ncXJPUV95bVl5RjZaVnpxZ0xhcTF4bzI2cWRlN3BFa2tqZTNPSjlQZlU1TGxSMlhvRl9SQlExMVdiS0hyNDRiSHZreDlRdE84a2V1VVJVU3d2WXI4UHNOaTMzZlBFTUxYOVZvdUtWVENiaFAteTZhNi1qWXc5azJLRXBuUi1SZ2ZJa3pGcVJiX3A4dTg2TXFMVkRXS0R4LUhsRURpQlgzUng3ejJqRFBZMW0tOA?oc=5","Fri, 18 Sep 2026 13:20:02 GMT","The Technical Signals Behind (AARD) That Institutions Follow Stock Traders Daily","Stock Traders Daily",{"title":198,"link":199,"pubDate":200,"description":201,"source":184},"AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky - Morningstar","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijgJBVV95cUxQTnpDUWoybnVoZkpyM0dGVzFuTDRsOHVLMkVTTDN6OHlva2dTS2Q5N0tQQy1hdHZJbWozUmRaRlVKQ2dFVGxtRXI0amZ3TEo0M0VhQkZadXhPUEM0QmtDUzZudGxWU3lPa1I1YzFXZGo3WkJ3Y3lrZ3plTmM4QWIydWZEWk5LWlhIbHZwcXZVNk5ZbDhOa1FDZGluY2MwWEJ0bEVxOGh3VnhsTlFHNkNfcHJPaVppRTkxelF3WGZXd3pVVHF4VGJYdS1FRllGR0ZRZDlndC01bEZJZ3hnZjl1NFFRLUVwaTJqNUFwQWxhOHZibkNiQmNkVzY1U1Zxa2trams2UHJ5M0tXRFdrdXc?oc=5","Wed, 30 Sep 2026 16:51:00 GMT","AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky Morningstar",{"title":203,"link":204,"pubDate":205,"description":206,"source":190},"AARD Shareholder Alert: Aardvark Therapeutics, Inc. - GlobeNewswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAJBVV95cUxPT0FVRnowNHVWQUo3dXFDbzhFOU9EMmRQU29LaWZVZ1hZeFBPWV9EcURha0loT3hiNGVjRmVYMEZoMWVHNmp1UDZ5Nkx4S1ZSb1FkeUt0b0h1RUJJa2trLXM5ZjlKSU9hemttNzM0WkJ4aGdWUjV4M1RQTWg3SDBzc1FpRkdCMUZjUFRBbXlVMlo1cGhVZ0hvcjZrTlRwZng2M0FHeWFTck9vSGhOd0JuNXV0QmpKWFRTUmNSVThDOEdzV05QcG5hZDZTaUlwVFVaQlp2V3dNQTdBRmZ5YzRPb0Rxa0JqdEt3UEd6aW5jU3ctWXdqSGlNd053czNZd2dvTU10YUs5SDluM0FTLW9jQTRnNlNXbHpHb1FZMVdhQnBzLWdYdXJPNw?oc=5","Mon, 28 Sep 2026 14:18:00 GMT","AARD Shareholder Alert: Aardvark Therapeutics, Inc. GlobeNewswire",{"title":208,"link":209,"pubDate":210,"description":211,"source":178},"AARD UPCOMING DEADLINE: SueWallSt Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm - PR Newswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijAJBVV95cUxON1hQWk13dzU3eWFDTnhwNG5RbGFrQnlEVHpWS0VnZXRXOHY3a2VSN0RYckRNY0F6NUp6WWVZMDBfTzNmSl96SlU1UEc1d0FRdF9TYTJtemxLMDNvbGtDMVYxaTZPeXliRTRCT3lGLTJnNjBIbk1pdnVpMFN2TDAteEw0LUFqa1BfUEJvTlN5TjZNTTQ0STdma3RMUkI1OEE1RGNDR2VFdDJ6aXVJZjNLc0dQQ1pFcU5QNzJCRXk0MDh6NzhRU241SmxLbjlsZmJIOFpsWDEzZXNfNHQ3dG9QZFc3dGttVTNfeEV2OEZqM0Z6bC1jZWEwaVVCUjFOY3B4RnhzMkYxUW5JWkJQ?oc=5","Thu, 01 Oct 2026 14:09:00 GMT","AARD UPCOMING DEADLINE: SueWallSt Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm PR Newswire",{"title":213,"link":214,"pubDate":215,"description":216,"source":196},"(AARD) Risk Channels and Responsive Allocation - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxPMFFCYy1uSl9lT0VCT2xLb2dBazFyaHdWRklZS1liUDlDd3R0QWNnXzRpQXBhZGwxanVLRTFXOXNHMm9Eci1rLWdlZzhnZ2JZMm9iWkJGRk9naWdmWlM3aENCZzhPMjM4UlhrTjRyV3VCUW1jZXdIcW9IR25RdDB2bUhUSllFdTlCOFNDamJ0UXpYUGlBdVVQd08xeGF5dVJDMGF3LXkyZzZaalRUa01wcXNTNUcyTXBYY1I0cjNjRU91QQ?oc=5","Mon, 28 Sep 2026 20:08:02 GMT","(AARD) Risk Channels and Responsive Allocation Stock Traders Daily",{"title":218,"link":219,"pubDate":220,"description":221,"source":184},"SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in Aardvark Therapeutics, Inc. Lawsuit - AARD - Morningstar","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijgJBVV95cUxOTnZ1amd6UzZ4N3ZJZFVXSUMtVF9yZ0h1cW5OX1llV2NGLXYtVXVjV1JkYlByOXRndUU3cThMR3ZhdWJjZmhYbmg5clMyTDE0RnhhTDZoR0xKTnVrMkVWdno1SDVUYWRsbkZMTkZNaEdiODRlRkZsVXIwUFdXNngtUTBfZDNKQmhIem9qbFY5S3NaTGVmQjYtNmlmdjhyaEVZSmpEY3lLeGFhWXpSdnBmZEZOd0RyVThTTzh5bV9Pa09zcVI1S2k5YTZvaEUyUnVBY18zZThOQ3FucEM4X3R4bG8tR3IxdDFLeUtlQkx6dmxhbEE5RER1dnkzQ2pFUklLQ0Z6bHluQU1XNnZNRGc?oc=5","Thu, 24 Sep 2026 14:11:00 GMT","SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in Aardvark Therapeutics, Inc. Lawsuit - AARD Morningstar",{"title":223,"link":224,"pubDate":225,"description":226,"source":178},"AARD DEADLINE NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 - PR Newswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimgJBVV95cUxPd2tBZkVGc3lxU2RrdU9PZXNwbjI0aC04UWNuZkZMSGVncGp1T2FBLUg1SnlfbzQ2bUdrVC0yT3luT01fX1V1eTN6TVdiVXBBS3FkYmNMUGhndHFLNVljQy1sdXVXYUVlZFkxTlhuaGgzMGRieWx2TlNzeV9Hd1F6T1R0OFJEYzZybzhEdUF4cTVqNGt5Vmk5R1ppREp5V1FYWE91QWphdmw0bkdYVF9CSmxFS0RmNUlkZ0xVYVl4M2NTUnZHN1pySUgtbTRZWmtGR2xGT0xrdkxLVHdnay1WUXZzenlJSkMzNno3ZEpkSmFNMDFXdXh3N3pHX1RfR2Y1MmVrQnRwd1ZkR0dHbE9FYzlhdm9HUGhLLVE?oc=5","Mon, 28 Sep 2026 18:04:00 GMT","AARD DEADLINE NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 PR Newswire",{"title":228,"link":229,"pubDate":230,"description":231,"source":184},"AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi-AFBVV95cUxOaU1sMGhZbXg3N0llX1M2dnkxa3RhVjQzQTZ0clpQQkpWd2JDM1M2SkpQWkhyVTl4X3B1TDlsNjIxaVhKaHNhb0tGYzFJYjExLU14QV9IejUzUlc1dFo5VW1BQWhtWEo3b3VoVkFwZmFNZ3lLMC0tYzduWmxjX3JoWW5hWVJQbUphb29HSE5ZanVkMDE2clhqWVdXeHJzcTRTamFmemdCeEtEYUU1SGNTSDJSZm02TzBteHZQUTFTN1hLTVNvYkJQazJKS0EtTGllTnhVTGstbXY4ZGFCbWdETHpjU0hIaFluOFJKbFowY3hyNGJTQk0xOA?oc=5","Tue, 29 Sep 2026 00:55:42 GMT","AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit Morningstar",{"title":233,"link":234,"pubDate":235,"description":236,"source":190},"Important Notice to Long-Term Shareholders of Aardvark - GlobeNewswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi7AJBVV95cUxNMzdHYkRjVHpKRjZtRElYb284eThPOWRIcEJHaldna2dSMDRNa2ZnSHY4dkJhSVlkdk9tdjFNSHN3STlDU3M5Mnh2YWJkc2xncllEVnpKbDkwYUplejR4eG95OTJ1S01Vb3R4ZnlEcUZBbUlyYkNFYzVZcjNyX0dsVjJsVUR3WllvZ3ZsX1lmWkdGY3dwUEJtNnRrbzJKdllFbjdTd25BalFxbU9HMk9uaTFjakVwQUlaMlBvWkVFVUtRNjVYZElZQmdvMzg1Y3FPQkI0RlZabklCOWoxa3ZocjVSSHE2SzlZMjExYTlVT1pYX0hsZzExRndiZTJSSkl2a1lORkVOR2R3Ym4yT0hSOE16SGtrYmlGMnlFWEtkNnhldm16TUZmWXU2b1htOXl0YktnYmxJcXV0R1RUelZObTdNWDNENmktSzZPNnpJR2NRdWpVVmhxRnhnVktELUlMN2F1amdhM0l1WkV4?oc=5","Tue, 22 Sep 2026 12:14:11 GMT","Important Notice to Long-Term Shareholders of Aardvark GlobeNewswire",{"title":238,"link":239,"pubDate":240,"description":241,"source":190},"AARD Investor Notice: Hagens Berman Alerts Investors in - GlobeNewswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 30 Sep 2026 14:41:18 GMT","AARD Investor Notice: Hagens Berman Alerts Investors in GlobeNewswire",{"title":243,"link":244,"pubDate":245,"description":246,"source":190},"Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, - GlobeNewswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirgJBVV95cUxNYzc2WF9HV2xJcV93cTFIb0V0MjVFZnpCeE9ZbnNFVmFPWThEMDdXeS02NV9NNEJkMGpaSm04X2tPOTRmQmtTUDZfN0JZdFp5QVBFY2ZkenJ3bG9ZTnpvRWFiLWhBeEpEajBqM0FnN2tUUDdSbVZVZVoyb3JncHo1ZW9xUW1hOW92alYwZy1RRkxyOFNyN3ZSWHpTdEhlblpTS2VELXg0U0F2T3p4alF2UVk5bDRraDFFSjdJMTdmdWpVcnoxcXdsNWhJWFNEWDlpVjlWMFNTRGZWTzh6VUtqWTdUc2tmVEFIdUZYZ2ZGRV9yNmRqc2FtU0ZzUGQ5NHBOVjZJdzdxQWZIMmUtXzQ3YTB2b0VDTWZwMkM1b3NDWkZlYmt0a3FCaUtlY1NXZw?oc=5","Wed, 30 Sep 2026 20:29:28 GMT","Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, GlobeNewswire"]